Blood pressure data. by Harry A. Quigley (695817)

Axial length and width. by Harry A. Quigley (695817)

The process of selecting participants. by Na Li (6550)

“…Chemotherapy was found to be protective factor for OS (HR = 0.33, 95%CI: 0.30–0.37)/CSS (HR = 0.44, 95%CI: 0.39–0.50) of ovarian cancer patients, while not receiving surgery remained a risk factor. …”

C-indexes for the nomograms. by Na Li (6550)

“…Chemotherapy was found to be protective factor for OS (HR = 0.33, 95%CI: 0.30–0.37)/CSS (HR = 0.44, 95%CI: 0.39–0.50) of ovarian cancer patients, while not receiving surgery remained a risk factor. …”

Multivariable model for percent axon loss. by Harry A. Quigley (695817)

Axon loss by treatment group. by Harry A. Quigley (695817)

Tonolab Calibration. by Harry A. Quigley (695817)

The dependency of thrombolysis on rt-PA concentration. by Jan Víteček (11434774)

Intracellular pH of <i>C</i>. <i>albicans</i> ATCC 90028; FLC-susceptible <i>C</i>. <i>albicans</i> D27and FLC-resistant <i>C</i>. <i>albicans</i> D15.9 with and without the treatm... by Mohammad Irfan (464459)

Pressure—strain estimates in load—unload protocol for losartan and control groups. by Harry A. Quigley (695817)

Average IOP after bead injection glaucoma. by Harry A. Quigley (695817)

Unfixed Peripapillary Thickness. by Harry A. Quigley (695817)

Low apolipoprotein A-I levels in Friedreich’s ataxia and in frataxin-deficient cells: Implications for therapy by QingQing Wang (1389630)

“…One also showed that there was no difference in serum Apo-A-I levels in FA when compared with controls. Using a highly specific stable isotope dilution mass spectrometry-based assay, we demonstrated a 21.6% decrease in serum ApoA-I in FA patients (134.8 mg/dL, n = 95) compared with non-affected controls (172.1 mg/dL, n = 95). …”

Length of whole blood clots from different amounts of blood in the in vitro middle cerebral artery model (diameter 3.1 mm). by Jan Víteček (11434774)

The effect of losartan on creep rate in ramp—hold inflation studies. by Harry A. Quigley (695817)

RTPCR of angiotensin receptor expression. by Harry A. Quigley (695817)

Results of the fitting process of the basic epidemiological model (i.e., without vaccinations). by Matthias Horn (78815)

AaERR directly regulates the expression of key enzymes in the CM pathway. by Dan-Qian Geng (18137370)

DataSheet_1_Dectin-1 Controls TSLP-Induced Th2 Response by Regulating STAT3, STAT6, and p50-RelB Activities in Dendritic Cells.pdf by Chao Gu (402478)

“…Dectin-1 stimulation induced STAT3 activation and decreased the transcriptional activity of p50-RelB, both of which resulted in reduced OX40L expression on TSLP-activated mDCs. …”

Antioxidation and Anti-Inflammatory Activity of Prussian Blue Nanozymes to Alleviate Acetaminophen-Induced Acute Liver Injury by Qiang Feng (88137)

“…Furthermore, the therapeutic mechanism studies have shown that PB nanozymes with abundant and variable valence states could not only directly scavenge ROS but also through the Keap1-Nrf2/HO-1 pathway to reduce oxidative stress. Moreover, the decreased expression levels of myeloperoxidase and F4/80 in the liver, which are markers of neutrophil and macrophage infiltration, indicated that the Prussian blue nanozymes modulates inflammation to protect against APAP-induced acute liver injury. …”